Deloitte announced the scaling of its Global Artificial Intelligence (AI) Simulation Center of Excellence (CoE), building on its global investment of $3B.

The latest Investment Monitor from Deloitte highlights a sustained downturn in business investment, driven by an increasingly ...

Applying new insights from GenAI to pattern and anomaly detection, computer vision, and robotics, the company can help ...

Gulf SWFs invested $82bn in 2023 and another $55bn in just the first nine months of 2024, representing two-thirds of all new ...

Popular diabetes and weight-loss drugs known as GLP-1s are helping to boost the biopharma sector's return on investment this year, according to a new report from consulting firm Deloitte.

Deloitte's Green hydrogen: Energizing the path to net zero report reveals that green hydrogen is moving into prime position as a solution for hard-to-abate sectors, and investments to help ...

One of the best-known names in Midlands dealmaking is to spearhead investment bank Cavendish's expansion into the region, targeting mid-market companies. Darren Boocock, a former Midlands Dealmaker of ...

Deloitte attributed the rising R&D costs to ... While R&D costs are up, so is the projected return on investment. For pharma R&D, the expected ROI was 5.9% in 2024, up from 2023’s 4.1%.

"But in this case, Deloitte's conduct has left us with no ... We sell different types of products and services to both investment professionals and individual investors. These products and ...

CFOs need to have a closer relationship with tech and IT leaders than ever before to craft forward-facing strategies, ...